HypothesisHighlightedLetter: balancing gut hydrogen as a proxy for bacteriotherapy benefits in irritable bowel syndromeMHID-3994699PMID: 324455282020Alimentary Pharmacology & TherapeuticsSergej M OstojicEDITORS, I have read with great interest the systematic review with meta- analysis written by Ianiro and co-workers,1 in which the authors have evaluated the efficacy of faecal microbiota transplantation (FMT, or bacteriotherapy) for the treatment of irritable bowel syndrome (IBS). Although only a handful of studies were eligible to be included in this meticulous analysis, the authors implied that
